Literature DB >> 9923585

Genetic polymorphism of CYP2D6 in North Indian subjects.

V Lamba1, J K Lamba, J B Dilawari, K K Kohli.   

Abstract

OBJECTIVES: CYP2D6 polymorphism of clinical relevance occurs with variable frequency in different ethnic groups. Since this polymorphism has not been studied in a North Indian population, the present study was undertaken.
METHODS: One hundred healthy unrelated North Indian subjects received 30 mg dextromethorphan (DM) orally at bed-time. The amounts of DM and its metabolite, dextrorphan (DR), excreted in 8 h urine were estimated by high performance liquid chromatography. Metabolic ratio (DM/DR excreted in 8 h) was used as an index of the metabolic status of an individual.
RESULTS: The analysis of the data by frequency distribution histogram, probit and NTV plots demonstrated bimodal distribution of the North Indian subjects with respect to hepatic CYP2D6. Out of 100 subjects, 97 were extensive metabolizers (EMs), whereas three were poor metabolizers (PMs). EMs and PMs excreted 29.82 and 2.67 micromol DR (mean value) and 2.59 and 8.82 micromol DM (mean value) in 8 h, respectively. MR and log MR was 197- and 2.2-fold higher in PMs versus EMs. The antimode value of zero was determined by visual observation in frequency distribution histogram and inflection point in probit plot.
CONCLUSION: From this study, it can be concluded that the PM phenotype of CYP2D6 occurs with a frequency of 3% (95% confidence interval of 0.33%-6.33%) in North Indians.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9923585     DOI: 10.1007/s002280050552

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  Genetic polymorphism of CYP2D6 in Tamil population.

Authors:  B K Abraham; C Adithan; J Mohanasundaram; C H Shashindran; K Koumaravelou; M Asad
Journal:  Eur J Clin Pharmacol       Date:  2001 Jan-Feb       Impact factor: 2.953

2.  Genetic polymorphism of CYP2D6 in a keralite (South India) population.

Authors:  B K Abraham; C Adithan; C H Shashindran; S Vasu; N A Alekutty
Journal:  Br J Clin Pharmacol       Date:  2000-03       Impact factor: 4.335

3.  Association of CYP2D6 100 C > T and 2850 C > T polymorphisms with generalized tonic clonic seizures among Indians.

Authors:  C C Soundararajan; A Adhin; M Tripathi; H K Prasad; S Jain; S Vivekanandhan
Journal:  J Neural Transm (Vienna)       Date:  2006-07-13       Impact factor: 3.575

4.  Genotype and allele frequency of CYP2D6 in Tamilian population.

Authors:  C Adithan; N Gerard; A T Naveen; K Koumaravelou; C H Shashindran; R Krishnamoorthy
Journal:  Eur J Clin Pharmacol       Date:  2003-08-27       Impact factor: 2.953

5.  Dextromethorphan metabolic phenotyping in an Iranian population.

Authors:  Minoo Afshar; Mohammadreza Rouini; Shahram Ala
Journal:  Eur J Clin Pharmacol       Date:  2005-01-19       Impact factor: 2.953

6.  Measurement of CYP2D6 and CYP3A4 activity in vivo with dextromethorphan: sources of variability and predictors of adverse effects in 419 healthy subjects.

Authors:  Christian Funck-Brentano; Pierre-Yves Boëlle; Céline Verstuyft; Célia Bornert; Laurent Becquemont; Jean-Marie Poirier
Journal:  Eur J Clin Pharmacol       Date:  2005-11-17       Impact factor: 2.953

7.  Drug monitoring of imatinib levels in patients undergoing therapy for chronic myeloid leukaemia: comparing plasma levels of responders and non-responders.

Authors:  N Singh; L Kumar; R Meena; T Velpandian
Journal:  Eur J Clin Pharmacol       Date:  2009-02-12       Impact factor: 2.953

8.  Clinical effectiveness of rivastigmine monotherapy and combination therapy in Alzheimer's patients.

Authors:  Nirmal Sonali; Manjari Tripathi; Rajesh Sagar; Thirumurthy Velpandian; Vivekanandhan Subbiah
Journal:  CNS Neurosci Ther       Date:  2012-12-04       Impact factor: 5.243

Review 9.  Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.

Authors:  Shu-Feng Zhou
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

10.  Prevalence of poor and rapid metabolizers of drugs metabolized by CYP2B6 in North Indian population residing in Indian national capital territory.

Authors:  Ekta Varshney; Nilanjan Saha; Monika Tandon; Vikesh Shrivastava; Shakir Ali
Journal:  Springerplus       Date:  2012-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.